• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pitfalls in the diagnosis of acromegaly.

作者信息

Pokrajac-Simeunovic Ana, Trainer Peter J

机构信息

Department of Endocrinology, Christie Hospital, Manchester, UK.

出版信息

Horm Res. 2004;62 Suppl 3:74-8. doi: 10.1159/000080504.

DOI:10.1159/000080504
PMID:15539804
Abstract

Acromegaly is a disfiguring and disabling illness which, when inadequately treated, reduces life expectancy. An implication of the ability to offer effective treatment is the increased onus on physicians of all sorts to ensure acromegaly is diagnosed and treated as early as possible. To this end, criteria for the diagnosis of acromegaly have been proposed in the consensus statement of Giustina et al. However, other data suggest that the proposed criteria are not rigorous enough and strict adherence to the guidelines would result in failure to diagnose a significant number of patients. A review of published experience suggests that the combination of a GH nadir during an oral glucose tolerance test of <0.25 microg/l plus a normal age-related insulin growth factor-I level makes the diagnosis of acromegaly extremely unlikely.

摘要

相似文献

1
Pitfalls in the diagnosis of acromegaly.
Horm Res. 2004;62 Suppl 3:74-8. doi: 10.1159/000080504.
2
Review of Cortina criteria for the diagnosis of acromegaly.肢端肥大症诊断的科尔蒂纳标准综述。
J Endocrinol Invest. 2005;28(11 Suppl International):70-2.
3
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.年龄会改变肢端肥大症术后患者口服葡萄糖后平均生长激素水平和生长激素最低点水平的诊断准确性。
Clin Endocrinol (Oxf). 2006 Aug;65(2):250-6. doi: 10.1111/j.1365-2265.2006.02584.x.
4
Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.口服葡萄糖后 GH 水平和 IGF-I 水平不一致,且肢端肥大症患者经治疗后 GH 水平降低:轻度疾病活动的生化标志物的精细化。
Horm Metab Res. 2010 Jan;42(1):50-5. doi: 10.1055/s-0029-1239522. Epub 2009 Oct 1.
5
Hormonal diagnosis of GH hypersecretory states.生长激素分泌过多状态的激素诊断。
J Endocrinol Invest. 2003;26(10 Suppl):27-35.
6
Dynamic tests and basal values for defining active acromegaly.用于定义活动性肢端肥大症的动态试验和基础值
Neuroendocrinology. 2006;83(3-4):200-4. doi: 10.1159/000095528. Epub 2006 Oct 13.
7
Current diagnostic guidelines for biochemical diagnosis of acromegaly.肢端肥大症生化诊断的现行诊断指南。
Minerva Endocrinol. 2004 Dec;29(4):207-23.
8
Are there alternative tests for diagnosis of acromegaly?是否有其他诊断肢端肥大症的检查方法?
J Endocrinol Invest. 2005;28(11 Suppl International):73-4.
9
GH and mortality in acromegaly.肢端肥大症中的生长激素与死亡率
J Endocrinol Invest. 2005;28(11 Suppl International):75-7.
10
Biochemical evidence supporting the Cortina criteria.支持科尔蒂纳标准的生化证据。
J Endocrinol Invest. 2005;28(11 Suppl International):81-3.

引用本文的文献

1
Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L.对胰岛素样生长因子-1升高且生长激素最低点>0.4μg/L但<1μg/L的患者进行长期随访。
Arch Endocrinol Metab. 2017 Sept-Oct;61(5):426-431. doi: 10.1590/2359-3997000000295. Epub 2017 Sep 18.
2
The problem of unrecognized acromegaly: surgeries patients undergo prior to diagnosis of acromegaly.未被识别的肢端肥大症问题:在诊断出肢端肥大症之前患者所接受的手术。
J Endocrinol Invest. 2015 Jun;38(6):695-700. doi: 10.1007/s40618-015-0245-3. Epub 2015 Feb 26.
3
Acromegaly and end-stage renal disease: a diagnostic challenge.
肢端肥大症与终末期肾病:一项诊断挑战。
J Endocrinol Invest. 2006 Sep;29(8):745-9. doi: 10.1007/BF03344187.
4
Update on the medical management of pituitary adenomas.垂体腺瘤的医学管理最新进展。
Curr Neurol Neurosci Rep. 2005 May;5(3):178-85. doi: 10.1007/s11910-005-0045-9.